Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor
- PMID: 1250243
- DOI: 10.1016/0027-5107(76)90256-6
Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor
Abstract
The degree of alkylation of haemoglobin was determined at different times after treatment of mice with one directly active alkylating agent, ethylene oxide, and one agent that requires metabolic activation, dimethylnitrosamine. Because of the random alkylation of red blood cells of various ages and the stability of alkylated haemoglobin, the amount of alkylated amino acids in haemoglobin decreases linearly with time, reaching the value zero after about 40 days, the life-span of erythrocytes in the mouse. This provides a basis for the use of haemoglobin as a monitor for integral doses of genotoxic environmental chemicals.
Similar articles
-
Use of alkylated proteins in the monitoring of exposure to alkylating agents.IARC Sci Publ. 1984;(59):189-98. IARC Sci Publ. 1984. PMID: 6545280
-
Evaluation of genetic risks of alkylating agents. III. Alkylation of haemoglobin after metabolic conversion of ethene to ethene oxide in vivo.Mutat Res. 1977 Nov;45(2):175-84. doi: 10.1016/0027-5107(77)90017-3. Mutat Res. 1977. PMID: 593285
-
Formation and subsequent removal of O6-methylguanine from deoxyribonucleic acid in rat liver and kidney after small doses of dimethylnitrosamine.Biochem J. 1978 Sep 1;173(3):739-48. doi: 10.1042/bj1730739. Biochem J. 1978. PMID: 708371 Free PMC article.
-
Enhanced repair of O6-alkylguanine in mammalian tissues.Folia Biol (Praha). 1984;30 Spec No:132-44. Folia Biol (Praha). 1984. PMID: 6427029 Review.
-
Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents.Mutat Res. 1990 Jul;231(1):11-30. doi: 10.1016/0027-5107(90)90173-2. Mutat Res. 1990. PMID: 2195323 Review.
Cited by
-
Interaction of 3,4,3',4'-tetrachlorobiphenyl metabolites formed by cytochrome P-450 in vitro with rat erythrocytes.Arch Toxicol. 1985 Oct;58(1):20-6. doi: 10.1007/BF00292611. Arch Toxicol. 1985. PMID: 3935092
-
Hydroxyethylvaline adduct formation in haemoglobin as a biological monitor of cigarette smoke intake.Arch Toxicol. 1988;62(4):247-53. doi: 10.1007/BF00332482. Arch Toxicol. 1988. PMID: 3240090
-
Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.Chem Res Toxicol. 2011 Aug 15;24(8):1169-214. doi: 10.1021/tx200135s. Epub 2011 Jun 20. Chem Res Toxicol. 2011. PMID: 21688801 Free PMC article. Review.
-
Blood protein conjugates and acetylation of aromatic amines. New findings on biological monitoring.Int Arch Occup Environ Health. 1985;56(3):179-96. doi: 10.1007/BF00396596. Int Arch Occup Environ Health. 1985. PMID: 4066048
-
A nonlinear dosimetric model for hemoglobin adduct formation by the neurotoxic agent acrylamide and its genotoxic metabolite glycidamide.Environ Health Perspect. 1993 Mar;99:221-3. doi: 10.1289/ehp.9399221. Environ Health Perspect. 1993. PMID: 8319628 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources